China plans to mass produce a vaccine to protect humans against the deadly bird flu virus after initial tests indicated it was safe, state media have said. The vaccine’s manufacturer, Sinovac Biotech Limited, announced it plans to produce 20 million vaccines annually within the next few years, the Beijing News and Xinhua news agency said Wednesday. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.